MIHAELA IOVANEL: Open Payments
NPI 1710094321 · CUMBERLAND, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,144 in 39 payments from 11 companies in 2025. Trend: 2023 $472 · 2024 $445 · 2025 $1,144
Food & beverage: $1,144
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $368 |
| PFIZER INC. | 10 | $194 |
| Lilly USA, LLC | 5 | $192 |
| Novo Nordisk Inc | 5 | $120 |
| ABBVIE INC. | 4 | $105 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: AIRSUPRA, ELIQUIS, KISUNLA, Rybelsus, VRAYLAR, FARXIGA, BREZTRI, JARDIANCE.
Industry payments across RI — which companies pay providers there.
